Related Experiment Video
Updated: Jun 22, 2026
08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial Cells
Gary W Liu1, Edward B Guzman1,2,3, Nandita Menon1,4
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Pharmaceutical Research
|February 3, 2023
Summary
Lipid nanoparticles (LNPs) offer a promising strategy for delivering nucleic acids to endothelial cells, crucial for treating chronic diseases like diabetes and cardiovascular disease. This approach targets gene expression within these cells for therapeutic benefit.
Area of Science:
- Vascular Biology and Gene Therapy
- Nanomedicine and Drug Delivery
Background:
- Endothelial cells maintain circulatory homeostasis and act as a gateway to vital organs.
- Endothelial cell dysfunction is implicated in chronic diseases including diabetes, cardiovascular disease, and cancer.
- Modulating endothelial cell gene expression presents a strategic therapeutic avenue for complex diseases.
Purpose of the Study:
- To review the functions of endothelial cells and identify upregulated receptors in health and disease.
- To explore the application of lipid nanoparticles (LNPs) for delivering various nucleic acids to endothelial cells.
- To discuss LNP characteristics, formulation, targeting strategies, and clinical translation for endothelial cell gene therapy.
Main Methods:
- Review of literature on endothelial cell biology and gene delivery systems.
- Analysis of LNP composition, morphology, and formulation techniques for endothelial cell targeting.
- Examination of clinical trial data and FDA-approved LNPs for gene therapy applications.
Main Results:
- LNPs are effective carriers for DNA, mRNA, circRNA, saRNA, siRNA, shRNA, miRNA, and ASO delivery to endothelial cells.
- Receptor upregulation in endothelial cells presents specific targeting opportunities.
- Various LNP formulations and delivery strategies show potential for therapeutic intervention.
Conclusions:
- Lipid nanoparticles represent a versatile platform for endothelial cell gene modulation.
- Targeting endothelial cells via LNP-mediated gene delivery holds significant therapeutic potential for chronic diseases.
- Overcoming challenges in LNP delivery and clinical application is key to realizing their full therapeutic promise.
